Company / Operating Income
Lexaria Bioscience Corp. Operating Income History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$5.8M
FY2025
5-year range
-$6.6M / -$5.7M
FY2021-FY2025
Trend
+12.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$7M to -$6M over the past 2 years.
Based on SEC 10-K filings.
-$6M in FY2025.
Improved from -$7M to -$6M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income increased 12.0% year-over-year.
- Peak operating income was recorded in FY2015.
- Lowest operating income in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -2.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$5.8M | +12.0% |
| FY2024 | -$6.5M | +1.3% |
| FY2023 | -$6.6M | -16.4% |
| FY2022 | -$5.7M | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2017 | - | - |
| FY2016 | -$2.0M | -27.2% |
| FY2015 | -$1.6M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026